Preparation and Evaluation of Fast-Disintegrating Effervescent Tablets of Glibenclamide

References

• R. Barbel, K. Gerolf, C. S. Peter. 1998. Optimization of an effervescent tablet formulation containing spray dried-l-leucine and polyethylene glycol 6000 as lubricants using a central composite design. Eur. J. Pharm. Biopharm. 46:85–94.
   PubMed Web of Science ®Google Scholar
• Y. X. Bi, H. Sunada, Y. Yonezawa, K. Danjo. 1999. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev. Ind. Pharm. 25:571–581.
   PubMed Web of Science ®Google Scholar
• Y. X. Bi, H. Sunada, Y. Yonezawa, K. Danjo, A. Ostuka, K. Iida. 1996. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem. Pharm. Bull. 44:2121–2127.
   PubMed Web of Science ®Google Scholar
• H. Blume, S. L. Ali, M. Stewart. 1993. Pharmaceutical quality of glibenclamide products. A multinational postmarket comparative study. Drug Dev. Ind. Pharm. 19:2713–2741.
   Web of Science ®Google Scholar
• R. L. Carr. 1965. Evaluating flow properties of solids. Chem. Eng. J. 72:163–168.
   Google Scholar
• S. N. Davis, D. K. Granner. 1996. Insulin, oral hypoglycemic agents and the pharmacology of endocrine pancreas. In A. G. Gilman. (Ed.), The pharmacological basis of therapeutics (9th ed., pp. 1487–1518 ). New York: McGraw-Hill.
   Google Scholar
• K. Dohney. 1993. You really expect me to swallow those horse pills?. Am. Drug. 108:34–35.
   Google Scholar
• M. A. El-Massik, I. A. Darwish, E. E. Hassan, L. K. El-Khordagui. 1996. Development of a dissolution medium for glibenclamide. Int. J. Pharm. 140:69–76.
   Web of Science ®Google Scholar
• H. Gucluyildiz, G. S. Banker, G. E. Peck. 1977. Determination of porosity and pore-size distribution of aspirin tablets relevant to drug stability. J. Pharm. Sci. 66:407–414.
   PubMed Web of Science ®Google Scholar
• H. H. Hausner. 1967. Friction conditions in a mass of metal powder. Int. J. Powder Metal. 3:7–13.
   Google Scholar
• T. Ishikawa, Y. Watanabe, N. Utoguchi, M. Matsumoto. 1999. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method. Chem. Pharm. Bull. 47:1451–1454.
   PubMed Web of Science ®Google Scholar
• R. Khankari, J. Hontz, S. Chastain, L. Katzner. 1999. International Patent Application No. 09/057, 84.
   Google Scholar
• K.-I. Koizumi, Y. Watanabe, K. Morita, N. Utoguchi, M. Matsumoto. 1997. New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int. J. Pharm. 152:127–131.
   Web of Science ®Google Scholar
• L. Lavie. 1986. Effervescent mixture characterized by protracted release of gas and the use of this mixture in the preparation of carbonated drinks, US Patent No. 4579742.
   Google Scholar
• A. Madan, A. Trehan, A. Vinod Kumar. 2004. Process for the preparation of fast dissolving dosage form, US Patent No. 20040258748.
   Google Scholar
• K. Marshall. 1987. In L. Lachman, H. A. Liberman, J. I. Kanig. (Eds.), The theory and practice of industrial pharmacy (3rd ed., pp. 66–99 ), Philadelphia, PA, USA: Lea & Febiger.
   Google Scholar
• R. Mohrle. 1989. Effervescent tablets. In H. A. Lieberman, L. Lachman, J. B. Schwartz. (Eds.), Pharmaceutical dosage forms: Tablets (2nd ed., Vol. 1, pp. 225–258 ), New York: Marcel Dekker, Inc.
   Google Scholar
• R. A. Neil, G. S. Banker, G. E. Peck. 1982a. Quantitative evaluation of pharmaceutical effervescent systems I: Design of testing apparatus. J. Pharm. Sci. 71:3–6.
   PubMed Web of Science ®Google Scholar
• R. A. Neil, G. S. Banker, G. E. Peck. 1982b. Quantitative evaluation of pharmaceutical effervescent systems II: Stability monitoring by reactivity and porosity measurements. J. Pharm. Sci. 71:7–13.
   PubMed Web of Science ®Google Scholar
• E. L. Parrot. 1981. Thermal hardness coefficient of tablets. J. Pharm. Sci. 70:328–329.
   PubMed Web of Science ®Google Scholar
• J. R. Robinson, J. W. McGinity. 2000. Effervescent granules and methods for their preparation, US Patent No. 6071539.
   Google Scholar
• C. Rong-kun, G. Xiaodi, A. B. Beth, A. C. Richard. 2000. Fast dissolving tablets. Pharm. Technol. 24:52–56.
   Google Scholar
• H. Seager. 1998. Drug-deliver products and the Zydis fast-dissolving dosage form. J. Pharm. Pharmacol. 50:375–382.
   PubMed Web of Science ®Google Scholar
• R. D. Shah, M. Kabadi, D. G. Pope, L. L. Augsburger. 1995. Physico-mechanical characterization of the extrusion-spheronization process. II: Rheological determinants for successful extrusion and spheronization. Pharm. Res. 12:496–507.
   PubMed Web of Science ®Google Scholar
• S. Smith. 1961. Stabilization of effervescent carbonate powders. US Patent No. 2984543.
   Google Scholar
• J. Swarbrick, J. Boylan. 2002. Encyclopedia of pharmaceutical technology (Vol. 1, pp. 1037–1049 ), New York: Marcel Dekker Inc.
   Google Scholar
• The United States Pharmacopoeia-24/National Formulary-19. 2000. Asian Edition. Rockville, MD: US Pharmacopeial Convention Inc., 1942.
   Google Scholar
• D. Train. 1958. Some aspects of the property of angle of repose of powders. J. Pharm. Pharmacol. 10 (Suppl):127T–135T.
   PubMedGoogle Scholar
• H. Walid, K. Raj, H. John. 2000. Fast dissolve drug delivery system. Crit. Rev. Ther. Drug Carrier Syst. 17:61–73.
   PubMed Web of Science ®Google Scholar
• F. Wehling, S. Scheuhle, N. Madamala, 1993. Effervescent dosage form with microparticles. US Patent No. 5178878.
   Google Scholar
• M. L. Wells, D. L. Wood, R. Sanftlesen, K. Shaw, J. Hottouy, T. Weber, J. M. Geoffray, T. G. Alkaire, M. R. Emptage, R. Sombia. 1997. Potassium carbonate as a desiccant in effervescent tablets. Int. J. Pharm. 152:227–235.
   Web of Science ®Google Scholar
• F. Witzel, K. W. Clark. 1978. Effervescent tablet and method. US Patent No. 4127645.
   Google Scholar